6-(4-chlorophenyl)-3-[(1-ethyl-1,2,5,6-tetrahydropyridin-3-yl)-methyl]-2-(2-methylphenyl)quinazolin-4(3H)-one

ID: ALA243702

PubChem CID: 11684223

Max Phase: Preclinical

Molecular Formula: C29H28ClN3O

Molecular Weight: 470.02

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN1CCC=C(Cn2c(-c3ccccc3C)nc3ccc(-c4ccc(Cl)cc4)cc3c2=O)C1

Standard InChI:  InChI=1S/C29H28ClN3O/c1-3-32-16-6-8-21(18-32)19-33-28(25-9-5-4-7-20(25)2)31-27-15-12-23(17-26(27)29(33)34)22-10-13-24(30)14-11-22/h4-5,7-15,17H,3,6,16,18-19H2,1-2H3

Standard InChI Key:  ZFIGUEXPUFIAPG-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
    5.4194   -2.2875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4182   -3.1148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1331   -3.5277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8495   -3.1144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8466   -2.2838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1313   -1.8747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5596   -1.8686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2768   -2.2830    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.2729   -0.6340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5559   -1.0473    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.9888   -1.0460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9849   -1.8690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6947   -2.2820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4087   -1.8732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4086   -1.0470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6982   -0.6377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2726    0.1910    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.8406   -0.6362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8391    0.1888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5544    0.6046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5548    1.4260    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8414    1.8410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1259    1.4284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1238    0.6008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1228   -0.6342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8353   -1.0506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5491   -0.6384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5491    0.1875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8295    0.5995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1186    0.1849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2629    0.6013    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    7.5646   -3.5257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2700    1.8372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9837    1.4233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 16 11  1  0
  3  4  2  0
  9 17  2  0
 10 18  1  0
  4  5  1  0
 19 18  1  0
 19 20  1  0
  7 10  1  0
  8 12  1  0
 11  9  1  0
  9 10  1  0
  2  3  1  0
 19 24  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
  5  6  2  0
 15 25  1  0
 11 12  2  0
 25 26  2  0
  6  1  1  0
 26 27  1  0
 12 13  1  0
 27 28  2  0
  1  2  2  0
 28 29  1  0
 13 14  2  0
 29 30  2  0
 30 25  1  0
  5  7  1  0
 28 31  1  0
 14 15  1  0
  4 32  1  0
  7  8  2  0
 21 33  1  0
 15 16  2  0
 33 34  1  0
M  END

Associated Targets(Human)

GHSR Tclin Ghrelin receptor (6229 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ghrelin receptor (39 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 470.02Molecular Weight (Monoisotopic): 469.1921AlogP: 6.34#Rotatable Bonds: 5
Polar Surface Area: 38.13Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.31CX LogP: 6.29CX LogD: 5.33
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.32Np Likeness Score: -0.90

References

1. Rudolph J, Esler WP, O'connor S, Coish PD, Wickens PL, Brands M, Bierer DE, Bloomquist BT, Bondar G, Chen L, Chuang CY, Claus TH, Fathi Z, Fu W, Khire UR, Kristie JA, Liu XG, Lowe DB, McClure AC, Michels M, Ortiz AA, Ramsden PD, Schoenleber RW, Shelekhin TE, Vakalopoulos A, Tang W, Wang L, Yi L, Gardell SJ, Livingston JN, Sweet LJ, Bullock WH..  (2007)  Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity.,  50  (21): [PMID:17887659] [10.1021/jm070071+]

Source